CABA
Price
$16.02
Change
-$0.03 (-0.19%)
Updated
Dec 1, 6:59 PM EST
102 days until earnings call
PDSB
Price
$5.25
Change
-$0.01 (-0.19%)
Updated
Dec 1, 6:59 PM EST
116 days until earnings call
Ad is loading...

CABA vs PDSB ᐉ Comparison: Which is Better to Invest?

Header iconCABA vs PDSB Comparison
Open Charts CABA vs PDSBBanner chart's image
Cabaletta Bio
Price$16.02
Change-$0.03 (-0.19%)
Volume$718.64K
CapitalizationN/A
PDS Biotechnology
Price$5.25
Change-$0.01 (-0.19%)
Volume$322.55K
CapitalizationN/A
View a ticker or compare two or three
CABA vs PDSB Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
CABA vs. PDSB commentary
Dec 04, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Buy and PDSB is a Hold.

COMPARISON
Comparison
Dec 04, 2023
Stock price -- (CABA: $16.02 vs. PDSB: $5.25)
Brand notoriety: CABA and PDSB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 123% vs. PDSB: 98%
Market capitalization -- CABA: $801.28M vs. PDSB: $183.54M
CABA [@Biotechnology] is valued at $801.28M. PDSB’s [@Biotechnology] market capitalization is $183.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 0 FA rating(s) are green whilePDSB’s FA Score has 0 green FA rating(s).

  • CABA’s FA Score: 0 green, 5 red.
  • PDSB’s FA Score: 0 green, 5 red.
According to our system of comparison, CABA is a better buy in the long-term than PDSB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 6 TA indicator(s) are bullish while PDSB’s TA Score has 5 bullish TA indicator(s).

  • CABA’s TA Score: 6 bullish, 4 bearish.
  • PDSB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CABA is a better buy in the short-term than PDSB.

Price Growth

CABA (@Biotechnology) experienced а -14.19% price change this week, while PDSB (@Biotechnology) price change was -16.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.15%. For the same industry, the average monthly price growth was +30.64%, and the average quarterly price growth was +27.15%.

Reported Earning Dates

CABA is expected to report earnings on Mar 14, 2024.

PDSB is expected to report earnings on Mar 28, 2024.

Industries' Descriptions

@Biotechnology (+3.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CABA with price predictions.
OPEN
A.I.dvisor published
a Summary for PDSB with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CABA($801M) has a higher market cap than PDSB($184M). CABA YTD gains are higher at: 73.189 vs. PDSB (-60.227). PDSB has higher annual earnings (EBITDA): -48.62M vs. CABA (-66.37M). CABA has more cash in the bank: 164M vs. PDSB (54.3M). CABA has less debt than PDSB: CABA (4.27M) vs PDSB (23.6M). CABA (0) and PDSB (0) have equivalent revenues.
CABAPDSBCABA / PDSB
Capitalization801M184M435%
EBITDA-66.37M-48.62M136%
Gain YTD73.189-60.227-122%
P/E RatioN/AN/A-
Revenue00-
Total Cash164M54.3M302%
Total Debt4.27M23.6M18%
FUNDAMENTALS RATINGS
PDSB: Fundamental Ratings
PDSB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CABAPDSB
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 18 days ago
85%
Declines
ODDS (%)
Bearish Trend 13 days ago
86%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIGIX19.120.20
+1.06%
Calamos International Growth I
HBLIX13.920.12
+0.87%
Hartford Balanced Income I
ESEIX31.980.23
+0.72%
Eaton Vance Atlanta Capital Sel Eq I
FLYCX31.310.20
+0.64%
Nuveen Large Cap Select C
HLEZX18.14N/A
N/A
Harding Loevner Instl Emerg Mkts Z

CABA and

Correlation & Price change

A.I.dvisor tells us that CABA and CDTX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CABA and CDTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
+15.42%
CDTX - CABA
33%
Poorly correlated
+10.08%
ORMP - CABA
32%
Poorly correlated
-4.05%
ICVX - CABA
32%
Poorly correlated
+3.75%
PSTX - CABA
31%
Poorly correlated
-1.12%
IOVA - CABA
29%
Poorly correlated
+3.13%
More